{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:18:33Z","timestamp":1761607113118,"version":"build-2065373602"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography B"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jchromb.2023.123901","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T04:37:27Z","timestamp":1696394247000},"page":"123901","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Determination of tamsulosin in plasma of healthy Chinese male subjects by a novel and simple LC-MS\/MS method and its application to pharmacokinetic studies"],"prefix":"10.1016","volume":"1229","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6835-5999","authenticated-orcid":false,"given":"Maolian","family":"Zhong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jchromb.2023.123901_b0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1569-9056(04)90505-2","article-title":"Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience","volume":"29","author":"Chapple","year":"1996","journal-title":"Eur. Urol."},{"issue":"5","key":"10.1016\/j.jchromb.2023.123901_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1440-1681.1994.tb02534.x","article-title":"Comparative study on alpha 1-adrenoceptor antagonist binding in human prostate and aorta","volume":"21","author":"Yamada","year":"1994","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"2 Pt 1","key":"10.1016\/j.jchromb.2023.123901_b0015","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0022-5347(17)35544-1","article-title":"Identification, quantification, and localization of mRNA for three distinct alpha 1 adrenergic receptor subtypes in human prostate","volume":"150","author":"Price","year":"1993","journal-title":"J. Urol."},{"issue":"Suppl 2","key":"10.1016\/j.jchromb.2023.123901_b0020","first-page":"S88","article-title":"Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate","volume":"147","author":"Michel","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123901_b0025","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1474-8673.1996.tb00352.x","article-title":"Drugs for treatment of benign prostatic hyperplasia: affinity comparison at cloned alpha 1-adrenoceptor subtypes and in human prostate","volume":"16","author":"Michel","year":"1996","journal-title":"J. Auton. Pharmacol."},{"issue":"2","key":"10.1016\/j.jchromb.2023.123901_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00002512-200219020-00004","article-title":"Tamsulosin: a review of its pharmacology and therapeutic efficacy in the management of lower urinary tract symptoms","volume":"19","author":"Dunn","year":"2002","journal-title":"Drugs Aging"},{"issue":"1","key":"10.1016\/j.jchromb.2023.123901_b0035","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2165\/00003495-200262010-00006","article-title":"Tamsulosin: an update of its role in the management of lower urinary tract symptoms","volume":"62","author":"Lyseng-Williamson","year":"2002","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.jchromb.2023.123901_b0040","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S0022-5347(17)39620-9","article-title":"Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group","volume":"144","author":"Kawabe","year":"1990","journal-title":"J. Urol."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123901_b0045","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2165\/00003495-199652060-00012","article-title":"A review of its pharmacological properties and therapeutic potential in the management of symptomatic benign prostatic hyperplasia","volume":"52","author":"Wilde","year":"1996","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.jchromb.2023.123901_b0050","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1021\/js960303k","article-title":"Disposition of the selective alpha1A-adrenoceptor antagonist tamsulosin in humans: comparison with data from interspecies scaling","volume":"86","author":"van Hoogdalem","year":"1997","journal-title":"J. Pharm. Sci."},{"issue":"3","key":"10.1016\/j.jchromb.2023.123901_b0055","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2165\/11317580-000000000-00000","article-title":"Pharmacokinetics and pharmacodynamics of tamsulosin in its modified-release and oral controlled absorption system formulations","volume":"49","author":"Franco-Salinas","year":"2010","journal-title":"Clin. Pharmacokinet."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123901_b0060","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1464-410X.1997.00411.x","article-title":"Clinical comparison of selective and non-selective alpha 1A-adrenoreceptor antagonists in benign prostatic hyperplasia: studies on tamsulosin in a fixed dose and terazosin in increasing doses","volume":"80","author":"Lee","year":"1997","journal-title":"Br. J. Urol."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123901_b0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2165\/00044011-200424010-00005","article-title":"Efficacy of low-dose tamsulosin on lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a nonblind multicentre korean study","volume":"24","author":"Park","year":"2004","journal-title":"Clin. Drug Invest."},{"issue":"Suppl 1","key":"10.1016\/j.jchromb.2023.123901_b0070","first-page":"63","article-title":"Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia","volume":"76","author":"Kawabe","year":"1995","journal-title":"Br. J. Urol."},{"issue":"12","key":"10.1016\/j.jchromb.2023.123901_b0075","doi-asserted-by":"crossref","first-page":"781","DOI":"10.2165\/00044011-200323120-00003","article-title":"Efficacy of low-dose tamsulosin in chinese patients with symptomatic benign prostatic hyperplasia","volume":"23","author":"Li","year":"2003","journal-title":"Clin. Drug Invest."},{"issue":"2","key":"10.1016\/j.jchromb.2023.123901_b0080","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0378-4347(97)00200-4","article-title":"Highly sensitive method for the determination of tamsulosin hydrochloride in human plasma dialysate, plasma and urine by high-performance liquid chromatography-electrospray tandem mass spectrometry","volume":"695","author":"Matsushima","year":"1997","journal-title":"J. Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.jchromb.2023.123901_b0085","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jchromb.2013.04.020","article-title":"Measurement of tamsulosin in human serum by liquid chromatography-tandem mass spectrometry","volume":"930","author":"Upreti","year":"2013","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"1","key":"10.1016\/j.jchromb.2023.123901_b0090","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-4347(01)00546-1","article-title":"Quantitation of tamsulosin in human plasma by liquid chromatography-electrospray ionization mass spectrometry","volume":"767","author":"Din","year":"2002","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"2","key":"10.1016\/j.jchromb.2023.123901_b0095","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jpba.2006.07.016","article-title":"Determination of tamsulosin in human aqueous humor and serum by liquid chromatography-electrospray ionization tandem mass spectrometry","volume":"43","author":"Keski-Rahkonen","year":"2007","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jchromb.2023.123901_b0100","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2012.10.012","article-title":"Determination of tamsulosin in human plasma by liquid chromatography\/tandem mass spectrometry and its application to a pharmacokinetic study","volume":"909","author":"Choi","year":"2012","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jchromb.2023.123901_b0105","unstructured":"ICH, BIOANALYTICAL METHOD VALIDATION AND STUDY SAMPLE ANALYSIS M10, 2022, https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf."},{"key":"10.1016\/j.jchromb.2023.123901_b0110","unstructured":"drugbank, Tamsulosin, 2005, https:\/\/go.drugbank.com\/drugs\/DB00706."},{"issue":"4","key":"10.1016\/j.jchromb.2023.123901_b0115","doi-asserted-by":"crossref","first-page":"181","DOI":"10.12793\/tcp.2020.28.e17","article-title":"Evaluation of the pharmacokinetics and food effects of a novel formulation tamsulosin 0.4 mg capsule compared with a 0.2 mg capsule in healthy male volunteers","volume":"28","author":"Ban","year":"2020","journal-title":"Transl. Clin. Pharmacol."},{"key":"10.1016\/j.jchromb.2023.123901_b0120","unstructured":"A.P. Inc., Harnal\u00ae D Tablets 0.1mg, 0.2mg: Pharmaceutical Interview Form, 2019, https:\/\/www.info.pmda.go.jp\/go\/interview\/1\/800126_2590008F1026_1_013_1F.pdf."},{"key":"10.1016\/j.jchromb.2023.123901_b0125","unstructured":"Sanofi-Aventis U.S. LLC FLOMAX\u00ae (tamsulosin hydrochloride, USP) Capsules, for oral use Initial U.S. Approval: 1997, 2019, https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/020579s033lbl.pdf."},{"issue":"6","key":"10.1016\/j.jchromb.2023.123901_b0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/17425255.4.6.771","article-title":"Tamsulosin modified release and oral controlled absorption system in the management of lower urinary tract symptoms suggestive of benign prostatic hyperplasia","volume":"4","author":"Schulman","year":"2008","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.jchromb.2023.123901_b0135","unstructured":"Z.P. D.O.O., Public Assessment Report of Tamsulosine HCl Zentiva 0.4 mg, prolonged-release tablets, 2015, https:\/\/db.cbg-meb.nl\/Pars\/h114204.pdf."}],"container-title":["Journal of Chromatography B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003112?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1570023223003112?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T23:12:29Z","timestamp":1761606749000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1570023223003112"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":27,"alternative-id":["S1570023223003112"],"URL":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123901","relation":{},"ISSN":["1570-0232"],"issn-type":[{"type":"print","value":"1570-0232"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Determination of tamsulosin in plasma of healthy Chinese male subjects by a novel and simple LC-MS\/MS method and its application to pharmacokinetic studies","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchromb.2023.123901","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"123901"}}